Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma

14 Oct 2020

Abstract excerpt

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide despite the availability of diverse treatment strategies. Much research progress has been made regarding immunotherapy but the effects remain unsatisfactory, highlighting the urgent need for novel immune-related therapy targets. In recent years, more and more studies have pointed out the associations between certain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33193690
DOI: 10.3389/fgene.2020.575776

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular CarcinomaPMID 33193690Read ↗

Prognostic value of TMEM147 in hepatocellular carcinoma correlates with immune infiltration of hepatocellular carcinomaSemantic proximity Read ↗

Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse gliomaSemantic proximity Read ↗

Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic modelSemantic proximity Read ↗

RBM39 is a potential prognostic biomarker associated with immune infiltrates in hepatocellular carcinomaSemantic proximity Read ↗

TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting M2 polarization of TAMsSemantic proximity Read ↗

CD58 as a biomarker for prognosis and immune infiltration in hepatocellular carcinomaSemantic proximity Read ↗

Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.Semantic proximity Read ↗

SLC17A2 Expression Correlates with Prognosis and Immune Infiltrates in Hepatocellular CarcinomaSemantic proximity Read ↗

Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping reviewSemantic proximity Read ↗

TMEM201 overexpression is associated with tumor progression and unfavorable prognosis in hepatocellular carcinomaSemantic proximity Read ↗

Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.Semantic proximity Read ↗

Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.